AbelZeta Presents Preclinical Data from Study of C-CAR168 for the Treatment of Autoimmune Diseases at ACR Convergence 2024 ...Middle East

Novel Anti-CD20/BCMA Bispecific Autologous CAR-T Therapy targeting LN and SLE ROCKVILLE, Md., Nov. 16, 2024 /PRNewswire/ -- AbelZeta Pharma, Inc. ("AbelZeta" or the "Company"), a global clinical-stage biopharmaceutical company focused on the discovery and development of innovative and...

Read More Details
Finally We wish PressBee provided you with enough information of ( AbelZeta Presents Preclinical Data from Study of C-CAR168 for the Treatment of Autoimmune Diseases at ACR Convergence 2024 )

Also on site :

• Man charged after homemade explosive device detonates in Yates Couunty
• ‘Saturday Night Live’ Opens With Donald Trump Signing Executive Orders, Including The “Belichick Law”: “Old Men Can Now Date Far Younger Women”
• Wind Advisory issued May 3 at 3:25PM PDT until May 4 at 4:00AM PDT by NWS Los Angeles/Oxnard CA